Retour
97
72
Fourchette du Jour
2,71 €
2,80 €
Fourchette 52 Semaines
2,60 €
4,31 €
Volume
11 769
Moyenne 50J / 200J
2,99 €
/
3,20 €
Clôture Précédente
2,71 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -13,7 | 0,4 |
| P/B | 0,8 | 2,9 |
| ROE % | -5,8 | 3,7 |
| Net Margin % | -3,6 | 3,8 |
| Rev Growth 5Y % | 46,7 | 10,0 |
| D/E | 0,8 | 0,2 |
Points Clés
Revenue grew 46,67% annually over 5 years — strong growth
Earnings declined -253,85% over the past year
Generating 87,85M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,45%
Capital efficient — spends only 1,99% of revenue on capex
ROIC of 29,48% — excellent capital efficiency
Croissance
Revenue Growth (5Y)
46,67%
Revenue (1Y)52,12%
Earnings (1Y)-253,85%
FCF Growth (3Y)22,72%
Qualité
Return on Equity
-5,80%
ROIC29,48%
Net Margin-3,59%
Op. Margin44,20%
Sécurité
Debt / Equity
0,82
Current Ratio1,03
Interest Coverage11,36
Valorisation
P/E Ratio
-13,73
P/B Ratio0,80
EV/EBITDA2,05
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 52,12% | Revenue Growth (3Y) | 34,27% |
| Earnings Growth (1Y) | -253,85% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 46,67% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,40B | Net Income (TTM) | -50,17M |
| ROE | -5,80% | ROA | -2,39% |
| Gross Margin | 37,50% | Operating Margin | 44,20% |
| Net Margin | -3,59% | Free Cash Flow (TTM) | 87,85M |
| ROIC | 29,48% | FCF Growth (3Y) | 22,72% |
| Safety | |||
| Debt / Equity | 0,82 | Current Ratio | 1,03 |
| Interest Coverage | 11,36 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -13,73 | P/B Ratio | 0,80 |
| P/S Ratio | 0,49 | PEG Ratio | 1,09 |
| EV/EBITDA | 2,05 | Dividend Yield | 0,00% |
| Market Cap | 689,04M | Enterprise Value | 1,27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,40B | 919,69M | 776,05M | 569,14M | 302,32M |
| Net Income | -50,17M | 32,61M | 82 000,0 | 1,37M | -43,79M |
| EPS (Diluted) | -0,03 | 0,13 | 0,00 | 0,01 | -0,23 |
| Gross Profit | 524,65M | 363,01M | 372,27M | 303,29M | 153,70M |
| Operating Income | 618,34M | -30,20M | 35,16M | 23,31M | -12,79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,10B | 1,81B | 1,41B | 1,32B | 1,26B |
| Total Liabilities | 1,06B | 877,55M | 563,16M | 503,78M | 554,37M |
| Shareholders' Equity | 862,80M | 867,61M | 767,67M | 732,34M | 618,24M |
| Total Debt | 710,38M | 425,09M | 426,28M | 358,42M | 401,94M |
| Cash & Equivalents | 133,65M | 131,67M | 43,42M | 48,91M | 61,92M |
| Current Assets | 369,30M | 346,11M | 176,40M | 150,88M | 142,91M |
| Current Liabilities | 357,17M | 382,08M | 152,95M | 136,50M | 137,30M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#2 of 616
Custom
Full Throttle
#11 of 146
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Full Throttle
Mar 24, 2026